Trials / Completed
CompletedNCT05015114
Prevalence and Factors of Sarcopenia and in Patients With Primary Sjogren's Syndrome
Prevalence and Factors of Sarcopenia in Patients With Primary Sjogren's Syndrome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Acibadem University · Academic / Other
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- —
Summary
Sarcopenia is a progressive condition characterized by decline in muscle strength and muscle mass. Although the mechanism of sarcopenia has not been fully elucidated, it may be caused by protein-poor diet, vitamin D deficiency, hormonal changes, increase in inflammatory cytokine level and oxidative stress. For this reason, it is thought that determining the prevalence of sarcopenia in rheumatological diseases with chronic inflammation and protecting patients from possible comorbidities with appropriate interventions may be an important factor in maintaining and improving the functional levels and quality of life of patients. The aim of our study was to investigate the prevalence and its associated factors of sarcopenia in individuals with primary Sjögren's Syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Sarcopenia Assessment | Sarcopenia Assessment |
Timeline
- Start date
- 2021-08-12
- Primary completion
- 2022-05-05
- Completion
- 2022-05-05
- First posted
- 2021-08-20
- Last updated
- 2022-05-25
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05015114. Inclusion in this directory is not an endorsement.